Intuitive Surgical stock: Baird keeps USD 513.00 target for Intuitive Surgical stock

Published on 10/19/2026 at 16:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 20, 2026. Intuitive Surgical stock costs EUR 382.20 on October 19, 2026, down 0.70 percent versus the Xetra close.

Analyst target and earnings date

Baird maintained a Buy rating and a USD 513.00 target on October 15, 2026.
Intuitive Surgical lists its third-quarter 2026 earnings call for October 20, 2026.
Intuitive Surgical stock costs EUR 382.20 at Lang & Schwarz on October 19, 2026 at 4:04 p.m. CEST, 0.70 percent below the Xetra close of October 16, 2026.
Intuitive Surgical had a P/E ratio of 48.84 and a market capitalization of USD 152.1 billion on October 19, 2026.

Flatlay mit Aktienzertifikat, ISIN-Karte, Stethoskop und Miniatur-Roboterarm auf weißem Untergrund — Flatlay-Arrangement mit Aktienzertifikat und ISIN-Karte symbolisiert Intuitive Surgical Inc. (US46120E6023) neben medizinischen Instrumenten und Kursdiagramm, Illustration mit AI erstellt.

According to Investing.com, Baird maintained a Buy rating and a USD 513.00 target for Intuitive Surgical on October 15, 2026. The target stands 19.18 percent above the USD 430.42 Nasdaq price on October 19, 2026. Intuitive Surgical was trading at EUR 382.20 at Lang & Schwarz on October 19, 2026 at 4:04 p.m. CEST, 0.70 percent below the Xetra close of October 16, 2026 at EUR 384.90.

Results arrive October 20, 2026

The next scheduled event is the third-quarter 2026 earnings call on October 20, 2026. The company lists the event in its investor-relations calendar at Intuitive Surgical. That date gives the analyst target a near-term test, because the market will compare new procedure demand and management commentary with current expectations.

Stock position in the annual range

The Nasdaq price was USD 430.42 on October 19, 2026 at 10:11 a.m. ET. It stood between the 52-week low of USD 328.57 and the 52-week high of USD 603.88, placing it 28.72 percent below the high. Trading volume was 590,392 shares against an average volume of 2,626,457 shares on October 19, 2026.

The euro quote and the Nasdaq quote describe separate venues. For investors in Germany, the Lang & Schwarz price is 0.70 percent below the dated Xetra close, while the Nasdaq quote provides the currency context for Baird's target.

Valuation meets the upcoming report

Intuitive Surgical had a market capitalization of USD 152.1 billion and a P/E ratio of 48.84 on October 19, 2026. Its 52-week range and valuation leave the October 20 report as the next dated test of the current analyst view. The Baird target is above the latest Nasdaq price, but the target and the euro quotation use different currencies and are not combined into one percentage.

Comparison with peers

Intuitive Surgical: minus 0.70 percent, P/E 48.84, market capitalization USD 152.1 billion.

Synaptics: plus 0.43 percent, P/E minus 9.32, market capitalization USD 4.7 billion.

Globus Medical: minus 0.76 percent, P/E 19.59, market capitalization USD 10.2 billion.

Price and investor calendar

The stock's immediate market frame combines a dated euro move, a 52-week position and an analyst target with the next earnings date. The October 20 report can add the next operating figures to that framework.

The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.